Cheil Bio Co

Cheil Bio Co EV/EBIT

Delisted·Feb 25, 2026

The EV/EBIT (Enterprise Value to EBIT) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -5.85. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -3.08 — a change of 90.06% (lower).

EV/EBIT

-5.85

YoY

90.06%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Cheil Bio Co is 2024 -5.85 . EV/EBIT (Enterprise Value to EBIT) of Cheil Bio Co was 2023 -3.08 . It decreases by 90.06% lower compared to the previous year.

The Cheil Bio Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2017
5.60 KRW
Jan 1, 2018
4.44 KRW
Jan 1, 2019
12.41 KRW
Jan 1, 2020
-12.73 KRW
Jan 1, 2021
-3.60 KRW
Jan 1, 2022
-3.96 KRW
Jan 1, 2023
-3.08 KRW
Jan 1, 2024
-5.85 KRW
The Cheil Bio Co EV/EBIT history
YEAREV/EBITYoY
-5.85+90.06%
-3.08-22.20%
-3.96+9.97%
-3.60-71.72%
-12.73-202.56%
12.41+179.16%
4.44-20.64%
5.60-29.78%
7.98+33.42%
5.98-1.89%
6.09-93.89%
99.69+464.50%
17.66-57.75%
41.80+1.78%
41.07-20.73%
51.81-620.18%
-9.96-73.70%
-37.87-89.11%
-347.65+525.49%
-55.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Cheil Bio Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Cheil Bio Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Cheil Bio Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Cheil Bio Co grows earnings faster than its peers.

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

EV/EBIT (Enterprise Value to EBIT) of Cheil Bio Co is -5.85 in 2024.

EV/EBIT (Enterprise Value to EBIT) of Cheil Bio Co changed from -3.08 to -5.85, representing a 90.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cheil Bio Co

All Key Metrics — Cheil Bio Co